Mastec Inc (MTZ)
NYSE · Price as of · Delayed Quote
- Analysts20
- Implied upside+94.4%
- Target range$321.00 to $518.00
- EPS expected$2.96 +19%
- A year ago$2.48
- Revenue expected$4.93B +24%
- Estimate range$2.85 to $3.04
Congress trades in MTZ
| Date | Member | Action | Amount | |
|---|---|---|---|---|
| 2026-08-21 | Thomas Kean NJ | Purchase | $1,001 - $15,000 |
SEC filings
| Form | Filed | Description |
|---|---|---|
| 4 | August 18, 2026 | FORM 4 |
| 4 | August 18, 2026 | FORM 4 |
| 4 | August 18, 2026 | FORM 4 |
| 4 | August 18, 2026 | FORM 4 |
| 4 | August 18, 2026 | FORM 4 |
| 4 | August 18, 2026 | FORM 4 |
| 4 | August 18, 2026 | FORM 4 |
| 4 | August 18, 2026 | FORM 4 |
Frequently asked questions
When does MTZ report earnings?
Mastec Inc (MTZ) is scheduled to report quarterly results on October 29, 2026, after the close. The 17-analyst consensus is $2.96 per share on revenue of $4.93B for the quarter ending September 30, 2026, against $2.48 and $3.97B a year earlier. It has beaten the consensus EPS estimate in 3 of the last four quarters.
What do analysts expect for MTZ?
20 analysts cover Mastec Inc (MTZ). The consensus rating is Strong buy. The average price target is $413.80, in a range of $321.00 to $518.00.
Are insiders buying or selling MTZ?
We have no qualifying Form 4 insider purchases or sales on record for Mastec Inc (MTZ). Sales are only tracked above a dollar threshold, so small routine trades may not appear.
Where can I see MTZ SEC filings?
Recent filings are listed on this page, newest first. The latest is a 4 filed August 18, 2026.